RIGL Rigel Pharmaceuticals, Inc. logo

RIGL Rigel Pharmaceuticals, Inc.

Healthcare
$28.64+0.00%OpenMarket Cap: $529.9M

As of 2026-05-26

Insider Statistics (Q1 2026)

Acquisitions

8

Dispositions

12

Buy/Sell Ratio

0.67

Net Shares

+62,450

Shares Acquired

224,372

Shares Disposed

161,922

Total Bought ($)

$0.00

Total Sold ($)

$0.00

Recent Insider Trades
Filing DateNameTypeActionSharesPriceShares After
Tue May 19Wasman JanedirectorSell5,750$0.0018,250
Tue May 19MOOS WALTER HdirectorSell5,750$0.0018,472
Tue May 19MILLER MICHAEL PATRICKdirectorSell5,750$0.005,937
Tue May 19LAPOINTE ANTHONY GREGGdirectorSell5,750$0.0018,250
Tue May 19HANNAH ALISON L.directorSell5,750$0.0016,375
Tue May 19Frohlich Mark WdirectorSell5,750$0.007,000
Tue May 19Ali-Jackson KamildirectorSell5,750$0.0015,125
Tue Feb 24MOOS WALTER HdirectorSell4,000$36.3612,722
Tue Feb 24MOOS WALTER HdirectorSell4,000$24.0016,722
Thu Feb 19Schorno Dean Lofficer: EVP & Chief Financial OfficerSell20,636$0.0076,337
Thu Feb 19Santos David Aofficer: EVP, Chief Commercial OfficerSell19,430$0.0062,870
Thu Feb 19Rojkjaer Lisaofficer: EVP, Chief Medical OfficerSell18,894$0.0034,853
Thu Feb 19RODRIGUEZ RAUL Rdirector, officer: CEO, PresidentSell53,915$0.00282,017
Thu Feb 19Furey Raymond J.officer: EVP, GC, CCO & Corp SecSell19,497$0.0051,813
Thu Feb 12Schorno Dean Lofficer: EVP & Chief Financial OfficerSell3,546$34.6255,701